Litigation Watch: ARTHRITIS DRUGS is a monthly newsletter for attorneys, focusing on drugs used to treat osteo and rheumatoid arthritis: Arava, Enbrel, Remicade, Humira, Vioxx, Celebrex and more. These drugs are already the subject of litigation following claims that they cause everything from liver damage to cancer, heart failure and strokes. Each issue features case news, interviews, legislative and FDA updates, and reviews from current medical literature.
Arthritis Drugs - Issue: 34
Pfizer Urges MDL Court to Reject Purchaser Plaintiffs' 'Market' Theory
Arthritis Drugs - Issue: 33
Federal Judge Certifies Investor Class in Celebrex Labeling Dispute
Calif. Judge Designates Single Case for State's Next Vioxx Trial
Judge: Staying State's Vioxx Suit Avoids Unnecessarily Prejudicing Merck
Research Watch, Arthritis Drugs, February 2007
N.J. Judge Orders Plaintiffs to Disclose Vioxx-Related Medical Records
Pharmacy Says State Law Precludes Liability, Duty to Vioxx Plaintiff
Plaintiff Can Pursue Claim that Physician Prescribed Excessive Vioxx Dose
